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Abstract
Background: ‘Exercise’ is universally recommended as a core treatment for knee and hip osteoarthritis (OA).
However, there are very few head-to-head comparative trials to determine the relative efficacy between different
types of exercise. The aim of this study is to benchmark different types of exercises against each other through
the use of a common comparator in a network meta-analysis of randomised controlled trials (RCTs).
Methods: This study will include only RCTs published in peer-reviewed journals. A systematic search will be
conducted in several electronic databases and other relevant online resources. No limitations are imposed on
language or publication date. Participants must be explicitly identified by authors as having OA. Interventions that
involved exercise or comparators in any form will be included. Pain is the primary outcome of interest; secondary
outcomes will include function and quality of life measures. Quality assessment of studies will be based on the
modified Cochrane’s risk of bias assessment tool. At least two investigators will be involved throughout all stages
of screening and data acquisition. Conflicts will be resolved through discussion. Conventional meta-analysis will
be performed based on random effects model and network meta-analysis on a Bayesian model. Subgroup analysis
will also be conducted based on study, patient and disease characteristics.
Discussion: This study will provide for the first time comprehensive research evidence for the relative efficacy of
different exercise regimens for treatment of OA. We will use network meta-analysis of existing RCT data to answer
this question.
Systematic review registration: PROSPERO CRD42016033865
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Background
Osteoarthritis (OA) is the most common form of arth-
ritis, characterised structurally by focal articular cartilage
loss, subchondral bone remodelling and changes in the
synovium, capsule and periarticular tissues [1]. The aeti-
ology of OA is multifactorial, and its prevalence is higher
in the elderly and in women [2]. The knee joint appears to
be more commonly affected than the hip [2]. It is a major
health burden and has been ranked 11th out of all
common causes of disability globally [3]. Patients with
symptomatic OA may experience substantial reduction
in quality of life (QoL), limitation in mobility and higher
mortality and morbidity [4, 5].
In the absence of any definitive cure [6, 7], non-
pharmacological therapy with adjunctive pharmacological
analgesic use are the mainstay of management in knee and
hip OA, with joint replacement surgery being reserved for
severe disease that is resistant to conservative manage-
ment [8, 9]. Pain-related limitation in physical activity and
lower limb muscle weakness are common problems in
knee and hip OA but are potentially reversible. Hence, ex-
ercise therapy is one of the core non-pharmacological
therapies universally recommended for all patients with
OA. Exercise therapy is as effective as pharmacological
agents in providing symptom relief and functional im-
provement, but without the serious side effects associated
with systemic analgesics [10].
Description of the intervention
Physical activity is defined as body movement that is
produced by the contraction of the skeletal muscles and
that increases energy expenditure, whereas exercise is
planned, structured and repetitive movement to improve
or maintain one or more components of physical fitness
[11]. Exercise has proven benefits in the various compo-
nents of health-related physical fitness—defined by the
American College of Sports Medicine (ACSM) to consist
of cardiorespiratory fitness, body composition, muscular
strength, muscular endurance and flexibility [12].
Exercise programmes are complex interventions that
vary with exercise type, frequency, intensity and dur-
ation, as well as the mode of delivery (individual-group,
supervised-unsupervised or facility-home-based). There
is a common tendency to pool clinical trial data on exer-
cise as an indistinct entity when formulating conclusions
on exercise effects [13]. Such results can be misleading
because the effects of exercise can be moderated by the
nature of the exercise programmes itself and by both pa-
tient and disease characteristics [14, 15].
Most exercise interventions for OA conventionally fall
into one of the following physical performance categor-
ies: strengthening, aerobic, flexibility and skills/balance.
In theory, the health benefits accrued are specific to the
type of exercise. For example, aerobic activity to improve
cardiorespiratory fitness can improve sleep and well-being
and reduce all-cause mortality, whereas strengthening pri-
marily improves local muscle function and proprioception
to improve joint stability and local biomechanical func-
tioning. However, there is evidence that both forms of ex-
ercise can reduce pain and improve function so both are
recommended in most recent guidelines [8, 11, 16].
Other than strengthening or aerobic exercises, range
of motion (ROM) exercise is also believed to be beneficial
in improving symptoms and function. This is especially
useful when functional and structural properties of peri-
articular soft tissue have been compromised following
acute knee swelling or prolonged joint immobilisation
[17]. Other types of exercise that incorporates ‘mind and
body’ components such as Tai Chi and Yoga are also gain-
ing interest for its role in improving symptoms and func-
tion [18]. It is possible that these may have additional
benefits such as modulation of the inflammatory response
[19] and reduction of central sensitisation in people with
OA [20].
As a result, an increasing number of exercise options
are being recommended [8–10]. However, relative effi-
cacy of different exercises (in terms of pain reduction,
improvement of function and quality of life) still remains
largely unknown. More interestingly, whether different
types of exercise can be tailored to individual patient
characteristics to maximise the benefits of exercise therapy
has yet to be investigated.
Importance of the project
Considering the complexity of trial designs involving ex-
ercise, it is unlikely that primary research can satisfactor-
ily provide a good overview relating to the efficacy of
each individual exercise—at least not without incurring
a huge demand in resources in order to perform mul-
tiple head to head comparison trials. For these reasons,
the comparisons between the effects of various exercises
may be examined more efficiently through a network
meta-analysis (NMA) using existing clinical trial data.
NMA is a method which attempts to estimate the
difference between two treatments (A and B) through
a common comparator (C) when the direct evidence
between these two treatments is not available [21]. There
may be several common comparators (nodes) shared by
different treatments at different levels. When common
comparators (nodes) are identified, treatments from differ-
ent trials can be networked. We will then be able to esti-
mate the relative effects of the different treatments
(exercises in this case) against each other through these
common comparators. In other words, the effects of dif-
ferent types of exercises in improving symptoms, function
and quality of life of patients with knee and hip OA can be
determined by integrating evidence from existing com-
parison trials.
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Methods
This protocol is prepared conforming to Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses Proto-
cols (PRISMA-P) as closely as possible (Additional file 1).
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) (including cross-
over and cluster randomised trials) which examine the
effects of exercise interventions in adults with knee or
hip OA in all settings will be included. Studies will be
considered as RCT if authors had explicitly stated that it
is randomised [22] or when randomisation cannot be
ruled out. Quasi randomised trials are excluded.
Participants
People with symptomatic OA of the knee and hip joint,
diagnosed clinically (e.g. American College of Rheumatol-
ogy Criteria), or radiographically (e.g. Kellgren Lawrence
grading), or by the use of other imaging (e.g. magnetic res-
onance imaging) will be included. There is no restriction
on the severity or stage of the disease. Hence, studies in-
volving patients from early to ‘end-stage’ OA, including
participants with pain following joint replacement, will be
considered.
Studies using mixed disease categories from which the
subgroup of knee and/or hip OA cannot be identified or
fail to explicitly specify the joint condition as OA will be
excluded. Arbitrarily, >80 % of joint replacement pa-
tients need to have their surgery attributed to OA in
order for the study to be included [23].
Interventions
Interventions that involve exercise prescribed in any
form, such as strengthening exercise, aerobic exercise or
mind-body exercise (e.g. tai-chi, yoga), will be eligible
for inclusion. In instances where the term ‘exercise’ is
not used by the investigators, any physical training that
fulfils the basic characteristics of exercise (i.e. a struc-
tured programme which is repeated/practised on a regu-
lar basis, e.g. three times a week) will also be included.
Single and combined interventions will be included, for
example exercise, ±adjunct treatment versus a non-
exercise intervention such as education, manual therapy
or electrotherapy. Additional file 2: Table S1 shows how
the pairwise comparisons from a study will determine its
eligibility.
Exercise will be classified based on four core exercise
types described by American College of Sports Medicine
(ACSM) [24]. An additional category of mind-body exer-
cise will also be included in our study. The classifications
are as follow:
(a)Strengthening/resistance exercise: exercise that aims
to improve the muscle’s ability to exert force and
involves applying resistance against a contracting
muscle.
(b)Aerobic exercise: exercise that aims to improve
cardiorespiratory fitness and involves repetitive
movement of large muscle groups, performed at
moderate to vigorous intensity for prolonged
periods of time.
(c)Flexibility exercise: exercise that improves the ability
to move a joint throughout its range of motion and
includes various types of stretching exercises.
(d)Neuromotor exercise: exercise that improves motor
skills such as balance and coordination.
(e)Mind-body exercise: exercise that combines a
physical exercise with meditation or mindfulness.
The latter is defined as the intention to be aware
and engaged in the present moment, i.e. attention
on your breath and movements without disturbed
by other issues [25]. It is a set of mindful movements
with a primary purpose of relaxation. The prototype
of this exercise includes Tai Chi, Qi Chong and Yoga.
If the authors had not clearly identified the exercise
element of interest, intervention that includes more than
one category of exercise will be categorised as mixed ex-
ercise. Other components (such as home based versus
class based) will be added to each if necessary to flag out
the difference. Further classifications may be made as
appropriate. SLG (a sports physician) and MH (a physio-
therapist) will be involved in classifying the exercise
interventions.
Comparators
All comparators which have been used in the exercise
trials will be included. However, for the purpose of the
network meta-analysis, we need to include a common
comparator across different exercises. The common
comparator is defined as the comparator which had been
used by at least two trials for two different exercises.
These could be a no treatment/attention control, a wait-
ing list control, a leaflet/education control, a ‘sham’ exer-
cise or an active control (another type of exercise or
intervention).
Outcomes
The primary outcome will be pain. Secondary outcomes
will include self-reported function, objective measured
function/physical test and QoL. Except for outcomes
based on physical testing, a hierarchical selection of
measurement scale following Fransen [26] and Regnaux
[27] will be adopted if more than one scale is being used
for the same outcome. However, a lower ranked scale
may be given priority over a higher ranked scale if (i) it
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is more comprehensively reported in the study or (ii) if
the direction of effect of the higher ranked scale is
unclear.
a. Primary outcome—pain
The hierarchical selection, in descending order of
preference, is as follows:
 Pain overall
 Pain on walking
 Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) pain subscale
 Pain on activities other than walking
 WOMAC global scale
 Lequesne osteoarthritis (OA) index global score
 Other algo-functional scale
 Patient’s global assessment
 Other outcomes
b. Secondary outcomes
(i) Functional outcomes—self-reported and objective
outcomes
Hierarchical selection for self-reported measures
in descending order of preference is as follows:
 Global disability score
 Walking disability
 WOMAC disability sub-score
 Composite disability scores other than
WOMAC
 Disability other than walking
 WOMAC global scale
 Lesquesne OA index global score
 Other functional scales
For objective performance-based outcomes, a
different consideration is used and may involve
identification of the commonest physical test
through ‘vote counting’—i.e. the test that is
reported by most studies. This is because no
physical tests, either singly or in combination, have
been deemed to be sufficiently investigated or
robust to warrant any definitive recommendations
for the assessment of physical function in hip and
knee OA patients [28]. Alternatively, if the
correlations between the tests are known, we
may consider pooling the results and generate
only one effect size estimate. In the event of any
discrepancies, a consensus will be sought within
the research team.
(ii)QoL
Hierarchical selection for QoL measures is as
follows:
 General health of short form (SF)-36 or SF-12
 EuroQol (EQ)-5D
 World Health Organization quality of life
 Mental/physical component summary of short
form (SF)-36
 Mental/physical component summary of short
form-12
 Sickness impact profile
 Nottingham health profile
 Other qualities of life scales
 Others
(iii)Others
If widely reported by authors, additional
measurements such as structural, biomechanical
or physiological parameters, including features on
imaging (radiographs, magnetic resonance
imaging, ultrasound), will also be included.
Study time points
There is no pre-specified study endpoint for eligibility.
Outcomes at different time points during the follow-up
period will be recorded, and the commonest point across
all trials will be used as a primary outcome point. Add-
itionally, outcome points during follow-up will be grouped
into intervals (e.g. ≤1 month, 1–3 months, 3–6 months,
6–12 months, 12–24 months etc.) for a secondary analysis
for the time-dependent effect.
Search methods for identification of studies
Search strategy
This meta-analysis aims to include all studies for exer-
cise therapy in OA published in peer-reviewed journals.
The following electronic bibliographic databases will be
systematically searched from their dates of inception: Al-
lied and Complementary Medicine Database (AMED),
The Cochrane Central Register of Controlled Trials
(CENTRAL), Cumulative Index to Nursing and Allied
Health Literature (CINAHL), Excerpta Medica Database
(EMBASE), MEDLINE, Physiotherapy Evidence Database
(PEDro), PubMed, SPORTDiscus and Google Scholar.
There will be no restrictions on languages. An example of
MEDLINE search is shown in Additional file 3.
The reference lists of systematic review protocols pub-
lished in Cochrane Library since 2014 will be used to
supplement the electronic database search. Abstracts
may be included if sufficient information for data extrac-
tion with/without risk of bias assessment is provided.
Publications of study protocols will be flagged pending
the full publication of the trial.
Data collection
Study selection process
Preliminary screening is by title and abstract. Full text of
potential citations will be retrieved for final screening
and data extraction. Study selection will be done by one
reviewer with the second reviewer performing periodical
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validations at random. A third reviewer will be involved
if any discrepancies arise—i.e. if either one of the re-
viewer is unsure or could not agree with each other.
Data extraction and management
A structured database is created in Microsoft Access for
data entry. In situation where studies are able to contrib-
ute two pairwise comparisons, data from four interven-
tion groups will be extracted, and the study will be
considered as two separate comparisons. Conversely,
studies that have produced companion publications may
be combined to maximise the yield of data.
When pairing of multiple groups cannot be performed
satisfactorily (such as when there are three groups in a
study), then combining groups may be considered. Sup-
posing that all intervention groups are eligible for inclu-
sion, exercise groups may be combined as a single group
to be compared against a single control group. The re-
verse will also be done if two control groups are eligible
but only one exercise group is available to contribute to
the comparison. Calculation of the standard deviation
for the composite group will be performed as described
by Cochrane Handbook [29] (Additional file 4). If there
is no clinical or practical justification to combine the
groups as described, the intervention or the comparator
that is deemed to be the simplest/commonest will be
chosen instead. The decision for adopting either ap-
proach will be described and explained in the table of
summary.
The following data will be extracted.
i. Study level include:
 Study identification details (i.e. title, author, year
of publication)
 Number of study arms
 Number of patients
 Duration of study
 Population: hospital/healthcare centre,
community
 Study design: parallel, crossover
ii. Participant level:
 Demographic: age, gender
 Associated risk factors: body mass index (BMI),
history of injury
 Diagnostic criteria used for recruitment
 Composition of patients with knee and hip OA
 Disease severity
iii. Intervention level
 Types of exercise: strengthening, aerobic,
balance/skills, flexibility/ROM, mind-body or
mixed,
 Measurement of exercise adherence
 Setting: group/class versus individual, hospital
versus home-based
 Compositions of patients with hip and knee OA
 Number of patients randomised
 Patient demographics by group
 Comparator types
 Baseline measurements
iv. Outcome level:
 Types of outcome and measurement tool used
 Are results adjusted
 Intention-to-treat (ITT) analysis
 Number of patients analysed/attrition at various
stages of study
 Types of effect size and relevant statistics
(standard deviation, confidence interval etc.)
 Primary and all measurement time points
An abridged data extraction form (Additional file 5)
will be used for data validation. The data extraction will
be performed by one reviewer while the second reviewer
will independently perform validation. Discrepancies in
data will be resolved through discussion between the
two reviewers. A third reviewer may also be involved if
needed.
Missing data
If the required data cannot be extrapolated from the
published article, attempts will be made to contact the
authors for additional information. Where this is not
possible, we will use statistical imputations as appropri-
ate. Details of imputations and assumptions used will be
reported.
As calculation of standard deviation is one of the com-
monly encountered situations, calculations for transform-
ing other forms of summary data to standard deviation
(SD) have been listed in Additional file 4. In studies where
insufficient information is provided for calculation, the SD
may be substituted with the widest SD obtained from
other eligible studies.
Analysis
Approach in analysis will flow from meta-analysis (MA)
to NMA and individual patient data (IPD) if the data are
available. The MA aims to confirm/update the efficacy
of different exercises, whereas the NMA aims to determine
the relative efficacy between different types of exercises.
The IPD meta-analysis aims to examine who responds
better to a specific exercise—that is, to determine predic-
tors of response. Data will be processed using various
softwares such as Microsoft Access, Excel, Stata and
WinBUGS/SAS.
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Unit of analysis
For calculation of effect size, the unit of analysis is the
mean (and standard deviation) of each trial. Demo-
graphic features of participants that were randomised to
each group at the commencement of studies will be de-
scribed. For the summary of effect, independent pairwise
comparisons will be the unit of analysis. This is to say, if
a study has four independent arms which can be paired,
the study will contribute two effect size estimates to the
meta-analysis. If a study has only three independent
arms, only one effect size will be synthesise for the sum-
mary of effect estimate.
Results of different outcomes and at different time
point will be reported separately. Any aggregation of
data will be indicated and justified.
Measures of treatment effect
The effect size of continuous data (pain, functional out-
come and QoL) will be based on standardised means differ-
ence, Cohen d. Whenever possible, the post-treatment
mean score will be used for calculation of effect size. If this
is not available, the mean change score will be used instead.
From Cohen d, a correction factor will be used to ob-
tain the unbiased effect size (Hedges’ g). Unless these
effect sizes are available by default in the statistical soft-
ware, calculations will be based on the equations listed
in Additional file 4. Point estimates of effect size will be
reported with its 95 % confidence interval for pairwise
meta-analysis and 95 % credibility intervals for NMA.
An exercise that is able to deliver minimal clinically
important difference (MCID) for the respective outcome
of interest (e.g. 30 % improvement in visual analogue
score from baseline, 20 % improvement in WOMAC
function from baseline) will be deemed as effective [30].
An exercise that is able to deliver a predefined MCID
compared to another (e.g. difference of 1 score on numer-
ical rating scale) will be considered as more efficacious.
Assessment of publication bias
Empirical methods to assess publication bias are not
considered to be better than visual assessment of funnel
plots [22]. Hence, we will use funnel plot to investigate
for publication bias which can be easily detected by
presence of gaps in the plot. This scatter plot of study
size against treatment effect will demonstrate a void at
the lower left section of the graph if the assumption that
studies with small sample size and non-significant effect
size tend to go unpublished is true.
Assessment of heterogeneity
We will use chi-squared (χ2) test to examine homogeneity
where level of significance is set at p < 0.1. To quantify the
impact of the heterogeneity on the pooled estimates, we
will use I2 statistics. The value of I2 indicates the magnitude
of heterogeneity in the analysis and is interpreted as: 0–
40 %—might not be important; 30–60 %—may represent
moderate heterogeneity; 50–90 %—may represent sub-
stantial heterogeneity; and 75–100 %—considerable het-
erogeneity [29]. Assessment of similarity and consistency
of the estimate will be performed to ensure that the direct
and indirect estimates agree. If the direct and indirect evi-
dence agree, the estimates will be pooled to increase the
power of the point estimates.
Risk of bias assessment
A modified Cochrane risk of bias assessment tool will be
used to assess the quality of studies [31] (Additional file 6).
This is an assessment tool that considers the various
sources of biases by examining the methods of random-
isation, concealment, blinding and handling of missing
data. Response for each criteria will either be yes, no or
unclear following the predefined guidelines as outlined
in Additional file 6.
 Was the randomization procedure adequate?
 Were there more than 100 subjects in each
treatment group?
 Was the treatment allocation adequately concealed?
 Were physicians blinded to the intervention?
 Were patients blinded to the intervention?
 Were outcome assessors blinded to the
intervention?
 Was incomplete outcome data adequately assessed?
 Was intention-to-treat analysis used?
 Were the treatment and control group similar at
baseline?
 Are all pre-specified outcomes of interest reported
in the pre-specified way?
Wherever a published protocol for the included study
is available, it will be used as a supplementary source of
information to enhance the quality assessment of the
trial protocol. Again, the assessment will be performed
by one reviewer with a second review performing ran-
dom validation in a sample of the included studies.
Quality criteria will be used for extended subgroup
analysis.
Data synthesis
ITT and adjusted results will be extracted whenever pos-
sible. If final scores and change from baseline score are
both reported, preference will be given to the final score.
For data that needs to be extracted visually from graphs,
the readings will be rounded to the nearest 0.5.
Random effects model will be used for all analyses. If
there are discrepancies between the direct estimates from
MA and indirect estimates from NMA—if the 95 %
confidence interval of the difference between the direct
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and indirect does not cross 0—we will consider the net-
work inconsistent. Further analysis will be performed
to identify the reason. However, the presence or ab-
sence of incoherence will not be determined solely on
statistical method since this method is also subjected to
statistical errors. Type I error (falsely assuming that
there is direct and indirect evidence are inconsistency)
can occur in a complex network because multiple tests
have to be performed. Type II error (falsely assuming
that the direct and indirect evidence are consistent)
can happen when the dataset in the network is small
[21]. Hence, the statistical significance of inconsistency
will be weigh against its clinical significance.
Other than assessing the discrepancy of the estimates,
the NMA will also be able to assess the strength and di-
versity of the treatment network. Comparisons that are
supported by a large number of RCTs can be distin-
guished from those that are informed by only a small
number of RCTs.
One major advantage of using Bayesian approach in
NMA is that it is able to produce a result for all compar-
isons in a connected network without the presence of a
common comparator. But on the other hand, different
prior distributions can be used which can generate dif-
ferent results, and therefore, a sensitivity analysis is al-
ways required. As prior knowledge on exercise efficacy is
inconclusive, a non-informative prior will be used in our
analysis. Posterior distributions of the model parameters
will be utilised to present the results of the NMA.
In IPD predictive regression modelling, only clinically
meaningful treatment and covariate interaction terms at
study and patient level will be investigated [32]. If sam-
ple size is deemed sufficient, different predictive model
may be explored for different subgroups. To minimise
loss of data, we will avoid dichotomizing continuous
predictors for analysis [33]—checks for linearity of
predictor-outcome relationship will be performed during
modelling. If there is a need to convert continuous pre-
dictor to categorical nature, this will be performed prior
to data analysis. Multiple imputations may be used to
address missing data.
Subgroup analysis
Extended subgroup analysis will be performed based on
the quality criteria of the study (sample size, blinding
etc.), patient characteristics (age, BMI, gender etc.), dis-
ease (severity, joint involved etc.), exercise and comparator
types. Other subgroup analyses will also be undertaken as
appropriate.
Sensitivity analysis
Sensitivity analysis will be performed to ascertain if the
results are robust. Situations where sensitivity analysis
will be indicated include (i) imputations of missing data
has been employed; (ii) when some arbitrary decisions
have been made with respect to study selection, sub-
group data aggregation/segregation; and (iii) when out-
lying studies are suspected. Small-study effect will be
specifically assessed as smaller studies tend to report
larger effect size and distort the summary estimates of
meta-analysis [34].
Meta-regression
Meta-regression will be used to assess the association of
various covariates in the model. This includes adjusting
for study level covariates such as mean age, gender ratio,
sample size, allocation concealment, blinding, duration
of treatment and type of exercise. Baseline severity of
the disease such as pain score may be included as a co-
variate when the post-treatment score has been used for
analysis in lieu of change score.
Discussion
Exercise is the cornerstone of treatment for patients
with lower-limb osteoarthritis. The results of this study
will provide evidence on relative efficacy of different
types of exercises in OA. It will also provide evidence on
which patient subgroup responds better to what type of
exercise. This information will help guide clinical prac-
tice to optimise exercise therapy in people with OA.
There are several caveats for this study. Firstly, classifi-
cation of exercise will be based on whatever the included
trials have reported. Exercise is a complex intervention,
and there is often overlap between the specific elements
involved in each exercise intervention. For example,
strengthening exercises often progress to involve an aer-
obic component and aerobic exercise involving lower limb
activity may result in strengthening of muscles relevant to
knee OA. Therefore, it is very difficult to have a clear cut
difference between different types of exercises.
Secondly, this is not a direct head to head comparative
study. The relative efficacy between exercises will be es-
timated from a common comparator indirectly using a
network meta-analysis. Variations between studies would
affect the estimate. We therefore aim to use Bayesian
statistics to increase the precision of the estimate. Even
so, we cannot guarantee that the relative efficacy of the
difference between exercises is a 100 % true value. Fur-
ther head to head comparison may still be needed to
confirm the results.
Thirdly, heterogeneity is an inherent problem in meta-
analysis because of the diversity in clinical and methodo-
logical characteristics. These variations include different
study time point, different grade of severity and duration
of intervention. Therefore, we will focus on identifying
the reason for the heterogeneity by performing sensitiv-
ity analyses and subgroup analyses. By doing this, we will
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be grouping studies that are more homogenous together
to synthesise a more precise summary of effect.
Another approach to assess the impact of heterogen-
eity is through the use of IPD which provides the means
to subgroup patients according to their characteristics.
Some of these subgroup characteristics may be the
source of heterogeneity that can be controlled at the
IPD level. IPD can also overcome the limitations of
study-level meta-regression where individual characteris-
tics are all averaged. However, IPD has some common
limitations. It only provides some but not all individual
characteristics for subgrouping, and these characteristics
often vary from one trial to another. As a result, only
limited information can be obtained from an IPD ana-
lysis [31]. Furthermore, getting the IPD data from pub-
lished trials is extremely difficult. The response rate is
often low; hence, the selection bias may be introduced
when only selective data are made available for the IPD
analysis. We will assess the impact of this bias on the
estimate by using aggregate data as substitute in both
1-stage and 2-stage analyses for studies without IPD.
Lastly, for both NMA and IPD, our search strategy is
relying heavily on electronic resources; publication bias
may not be avoided. We will therefore estimate this
bias in the analysis.
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